AGED Diagnostics
PrivateLast Round
Convertible Debt
Sep 6, 2023
Total Funding Raised
$450,000
Company Overview
AGED Diagnostics is a biotechnology company that develops noninvasive blood-based diagnostic tests for liver diseases, including MASH and liver fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AGED Diagnostics Comparables
Compare AGED Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hepta Bio | 94% | |
| Glycotest, Inc. | 80% | |
| Illumina, Inc. | 76% |
AGED Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 6, 2023 |
Key People
Founding team and executive leadership
AGED Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Convertible Debt |
| Central Texas Angel Network | Seed |
| Intelligence Ventures | Seed |
| Life Science Angels | Seed |
| How Women Invest | Convertible Debt |
| Gloucester Ventures | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2024
Grew 300% QoQ from 1 to 4 employees.
- Sep 6, 2023
$450K round led by TEDCO
AGED Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AGED Diagnostics's valuation, stock price, and market status.
Is AGED Diagnostics a public or private company?
AGED Diagnostics is a private company.
What is the current stock price of AGED Diagnostics?
AGED Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is AGED Diagnostics worth (valuation)?
Valuation information for AGED Diagnostics is not publicly available.
Can I buy AGED Diagnostics stock?
AGED Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AGED Diagnostics's last funding round?
AGED Diagnostics's most recent funding round was Convertible Debt on September 6, 2023.
Who are the main investors in AGED Diagnostics?
Key investors in AGED Diagnostics include TEDCO.
Will AGED Diagnostics IPO soon?
No public IPO plans have been announced for AGED Diagnostics.
How can I track AGED Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AGED Diagnostics's secondary market activity and sign up for updates.